BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19620798)

  • 1. [Prognostic factors and usefulness of chemotherapy with S-1 in patients received gastrectomy for stage IV gastric cancer].
    Maehara N; Hidaka H; Nagaike K; Nakashima S; Hotokezaka M; Chijiiwa K
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1111-4. PubMed ID: 19620798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful downstaging by S-1-based chemotherapy followed by surgical resections for gastric carcinoma with extensive distant lymph node metastasis - report of two cases and a review of cases with surgical resection after downstaging by S-1-based chemotherapy.
    Yoshida I; Sakurai Y; Komori Y; Tonomura S; Masui T; Shoji M; Nakamura Y; Imazu H; Uyama I; Ochiai M
    Hepatogastroenterology; 2005; 52(63):978-84. PubMed ID: 15966245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognosis and clinical course of gastric cancer with para-aortic lymph node metastasis after curative D2 gastrectomy and adjuvant chemotherapy with S-1].
    Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2331-3. PubMed ID: 22202372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cisplatin and S-1 combination therapy after reduction surgery for stage IV gastric cancer].
    Taniwaki S; Saruwatari A; Yoshida T; Mizoguchi A; Kitasato Y; Kitamura T; Hidaka A; Shiota K; Kuroda H; Tanaka M; Higashi T; Iwanaga Y; Ogata Y
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):279-82. PubMed ID: 19223745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of S-1 adjuvant chemotherapy on survival following recurrence and efficacy of first-line treatment in recurrent gastric cancer.
    Hasegawa H; Fujitani K; Kurokawa Y; Hirao M; Nakazuru S; Mita E; Tsujinaka T
    Chemotherapy; 2010; 56(6):436-43. PubMed ID: 21088394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination therapy of S-1 and 24-h infusion of cisplatin after palliative gastrectomy for stage IV gastric cancer].
    Ina K; Hibi S; Furuta R; Takeuchi Y; Nagao S; Kayukawa S; Masaki A; Kataoka T
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):251-4. PubMed ID: 20154479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of Stage IV AFP producing gastric cancer with long-term survival treated by adjuvant chemotherapy with S-1].
    Sano T; Usuki H; Takebayashi R; Akamoto S; Inoue T; Kakinoki K; Hagiike M; Okano K; Izuishi K; Suzuki Y
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):521-6. PubMed ID: 20332696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two cases of long-term survival with CY1, stage IV gastric cancer due to surgery and postoperative chemotherapy].
    Tanida T; Aoki T; Igarashi Y; Tsukao Y; Komori T; Matsumoto T; Takachi K; Nishioka K; Uemura Y; Kobayashi K
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2063-5. PubMed ID: 19106524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pilot study of neo-adjuvant chemotherapy involving intraperitoneal administration of paclitaxel and oral S-1 for patients with T3 gastric cancer].
    Tamura S; Miki H; Okada K; Yoshimura M; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2024-6. PubMed ID: 19106511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer.
    Aoyama T; Yoshikawa T; Shirai J; Hayashi T; Yamada T; Tsuchida K; Hasegawa S; Cho H; Yukawa N; Oshima T; Rino Y; Masuda M; Tsuburaya A
    Ann Surg Oncol; 2013 Jun; 20(6):2000-6. PubMed ID: 23242818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.
    Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predictive of recurrence after surgery for gastric cancer followed by adjuvant S-1 chemotherapy.
    Wada T; Kunisaki C; Hasegawa S; Takagawa R; Momiyama M; Kosaka T; Makino H; Ono HA; Oshima T; Akiyama H; Endo I
    Anticancer Res; 2013 Apr; 33(4):1747-51. PubMed ID: 23564827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two cases of stage IV gastric cancer responding to chemotherapy with S-1 or UFT].
    Nakamura Y; Yumiba T; Yamasaki Y; Momiyama T; Ito A; Akamaru Y; Sugimoto Y; Tamaoka N; Beppu N; Watanabe Y; Ohno K; Kasugai T
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1463-6. PubMed ID: 17876147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case report of curative resection for gastric cancer with peritoneal dissemination successfully treated by combined chemotherapy of S-1 and paclitaxel].
    Yamaki S; Iwata S; Ohtsuka K; Kitaoka A; Masumoto H; Katoh H
    Gan To Kagaku Ryoho; 2008 May; 35(5):821-3. PubMed ID: 18487921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of S-1 for advanced gastric cancer after reduction surgery].
    Inaba Y; Hayashi K; Miura T; Moriya T; Takiguchi M; Isobe H; Watabe S
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1053-7. PubMed ID: 17637541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of patients with locally advanced gastric cancer undergoing gastrectomy after pre-operative chemotherapy including S-1].
    Kinouchi M; Shibata C; Miura K; Okabe M; Andou T; Kakyou M; Saijou F; Haneda S; Ogawa H; Unno M; Sasaki I
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1481-4. PubMed ID: 19755816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of prognostic factors for the response to S-1 in patients with stage II or III advanced gastric cancer who underwent gastrectomy.
    Ishido K; Azuma M; Koizumi W; Takeuchi A; Sakuramoto S; Watanabe M; Okayasu I
    Pharmacogenet Genomics; 2009 Dec; 19(12):955-64. PubMed ID: 19898266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of S-1 for stage IV gastric cancer].
    Kanazawa Y; Furukawa K; Yamada T; Shirakawa T; Fujita I; Kato S; Yokoi K; Uchida E
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1619-22. PubMed ID: 21996955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Examination of continuity of S-1 adjuvant chemotherapy for gastric cancer patients after gastrectomy].
    Kawabata R; Imamura H; Kishimoto T; Anami S; Yasui Y; Fujino M; Fujii C; Sumida R; Furukawa H
    Gan To Kagaku Ryoho; 2011 May; 38(5):793-5. PubMed ID: 21566439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.